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ABSTRACT
The genome of a multi-cellular organism acquires
various functional capabilities in different cell
types by means of distinct chromatin modifications
and packaging states. Acquired during early devel-
opment, the cell type-specific epigenotype is
maintained by cellular memory mechanisms that
involve epigenetic modifications. Here we present
the epigenetic status of the euchromatic region
of the human Y chromosome that has mostly
been ignored in earlier whole genome epigenetic
mapping studies. Using ChIP-on-chip approach,
we mapped H3K9ac, H3K9me3, H3K27me3 modifi-
cations and CTCF binding sites while DNA methyla-
tion analysis of selected CpG islands was done
using bisulfite sequencing. The global pattern of
histone modifications observed on the Y chromo-
some reflects the functional state and evolutionary
history of the sequences that constitute it. The com-
bination of histone and DNA modifications, along
with CTCF association in some cases, reveals the
transcriptional potential of all protein coding genes
including the sex-determining gene SRY and the
oncogene TSPY. We also observe preferential asso-
ciation of histone marks with different tandem
repeats, suggesting their importance in genome or-
ganization and gene regulation. Our results present
the first large scale epigenetic analysis of the human
Y chromosome and link a number of cis-elements to
epigenetic regulatory mechanisms, enabling an
understanding of such mechanisms in Y chromo-
some linked disorders.
INTRODUCTION
The human genome generates about 220 cell types and
thousands of functional states. This multiplicity of pheno-
typic output is possible by epigenetic regulatory mechan-
isms that involve DNA methylation and a rich variety of
histone modiﬁcations (1,2). In general, histone acetylation
correlates with active state of chromatin whereas DNA
methylation correlates with inactive chromatin. Histone
methylation leads to active or inactive chromatin depend-
ing on the site of methylation of the histone tail (3).
Tri-methylation of H3K4, H3K36 and H3K79 mark
active chromatin whereas tri-methylation of H3K9,
H3K27 and H3K56 mark inactive chromatin.
Combinations of histone modiﬁcations provide further di-
versity in marking speciﬁc epigenetic signatures of a cell
and are a crucial determinant of its fate (4,5). Cytosine
methylation of DNA is the most widely studied epigenetic
modiﬁcation and has been found to be associated with
tissue, germ line and cancer speciﬁc genes (1,6,7). CpG
islands, the target of DNA methylation, are part of
60% of all promoters in the human genome (8).
Histone hypoacetylation and hypermethylation at
speciﬁc residues of core histone proteins are also
correlated with DNA methylation, showing that there is
an association between histone modiﬁcations and DNA
methylation which ﬁnally determines the state of chroma-
tin. Histone modiﬁcations, together with DNA methyla-
tion, have a vital role in organizing nuclear architecture
and are involved in regulating transcription and other
nuclear processes (1,9). These epigenetic marks not only
reﬂect the cell type-speciﬁc functional state of the genome
but also play an important role in maintaining that func-
tional state during cell cycle and development (10–12).
The Y chromosome is one of the smaller chromosomes
(57Mb) in the human genome (13,14) and has been
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sexdeterminationandevolutionaryhistory(15–17).Except
for the small pseudoautosomal regions on both ends, no
other part of the Y chromosome participates in meiotic
recombination. The absence of recombination makes it
very special not only for medical and forensic reasons but
also to study human evolution (18). Non-recombining
region of Y chromosome (NRY) or Male speciﬁc Y
chromosome (MSY) has 40% (23Mb) euchromatin
and 60% (40Mb) heterochromatin. It has poor gene
density and has often been considered as a collection of
junk DNA except for the sex-determining region. This
view is gradually changing and now, many phenotypes
have been attributed to the Y chromosome, including
spermatogenesis, cerebral asymmetry, stature, tooth size,
handedness, testoblastoma and male speciﬁc cancers
(16,19–24). The pseudoautosomal regions present at the
short (p) and long (q) arm contain 16 and 3 coding genes,
respectively, whereas the euchromatic region of MSY
contains 156 transcriptional units, half of which code for
proteins. Because of internal duplications, these 78 genes
code for only 27 distinct proteins (13,16). Of the 27 genes,
12 are expressed ubiquitously, 11 are expressed exclusively
or predominantly in testis and the remaining 4 are
expressed only in teeth and brain (16). Repeat elements
are widespread in the Y chromosome and it has been
postulated that some of these repeat elements may have a
role in genome packaging and coordinated expression of
genes (25).
These observations imply that though the Y chromo-
some has very few genes, it employs a variety of regulatory
mechanisms for its function. Because of these features, we
chose the Y chromosome for epigenetic analysis, generally
neglected in whole genome epigenetic mapping studies
(1,2,26,27) presumably because of the presence of many
repeats and the instability of the chromosome in various
cultured cell lines. To overcome both these limitations, we
decided to analyze chromatin obtained from white blood
cells (WBCs) of individuals and perform ChIP-on-chip
using Y chromosome speciﬁc probes from both unique
and duplicated regions. In this study we have mapped
H3K9ac, H3K9me3, H3K27me3 histone modiﬁcations
and binding sites of CTCF, a conserved chromatin
protein with multiple functions including a role in chro-
matin domain boundary (28–31), across the euchromatic
region of human Y chromosome using ChIP-on-chip tech-
nique. DNA methylation analysis of some CpG islands
associated with Y-chromosome genes was also done
using bisulﬁte sequencing method. Our results provide
for the ﬁrst time an epigenetic view of the MSY euchroma-
tin. The distinct patterns of histone marks associated with
different types of sequences on the chromosome are also
indicative of the epigenetic mechanisms that regulate most
of the genes and tandem repeats.
MATERIALS AND METHODS
Sample collection and isolation of white blood cells
Blood samples of male individuals, one each from the two
distinct populations, South Indian (Tamil Nadu) and
North Indian (Jammu and Kashmir) populations were
collected (32). The sample collection was done as per in-
stitutional ethical guidelines. The blood samples were
diluted 4 times in ELB (erythrocyte lysis buffer: 155mM
NH4Cl, 10mM KHCO3, 0.1mM EDTA pH 7.4) and
incubated on ice for 30min. After centrifugation at
2500rpm for 10min at room temperature, the supernatant
was carefully removed and the pellet was re-suspended
thoroughly in ELB. Again, centrifugation at 2500rpm
for 10min at room temperature was done to pellet down
white blood cells (WBCs) and the pellet was ﬁnally resus-
pended in 1 PBS. Cells were cross-linked immediately by
incubation in 1% formaldehyde for 10min at room tem-
perature. Cross-linking was stopped by the addition of
125mM glycine. For future use, cells were snap frozen
and stored at 80C.
Chromatin immuno-precipitation
Chromatin immuno-precipitation (ChIP) was carried out
as per the Upstate kit (catalog 17–295) protocol. In brief,
about 10
8 cross-linked cells were resuspended in 2ml SDS
lysis buffer containing protease inhibitors. After 10min of
incubation on ice, 200ml aliquots were sonicated using
Bioruptor (Diagenode). These aliquots were pooled,
mixed well and again split into 200ml aliquots. Then
ChIP was done using H3K9Me3 (Upstate), H3K9ac
(Upstate), H3K27Me3 (Upstate) and CTCF (Abcam)
antibodies on WBCs of two different individuals, 8 experi-
ments in total. To rule out experimental errors, we per-
formed two more ChIPs with the South Indian sample,
using H3K9Me3 and H3K9ac antibody. So, ten ChIP
experiments were done using four antibodies for two
samples and keeping two duplicates with the South
Indian sample. After ChIP, DNA recovered from the
bound fraction was used for the microarray experiment.
Microarray
A custom made Human Y chromosome speciﬁc micro-
array chip manufactured by Agilent Technologies was
used. About 95049 non-overlapping probes varying in
size from 44 to 60nt from the euchromatic region were
spotted on microarray chip. The array contained 50220
unique probes, 34501 probes for multi-copy loci spotted
once on the microarray chip and 4735 probes for
multi-copy loci spotted multiple times (total 10328).
About 44829 probes designed for multi-copy loci
covered sequences like pseudoautosomal region, tandem
repeats, palindromes and multi-copy TSPY gene. ChIP
DNA was used for the hybridization as per the
Mammalian ChIP-on-chip Protocol of Agilent
Technologies. Data was extracted from scanned micro-
array slides using Agilent Feature Extraction Software 9.
Output ﬁles from the Feature Extraction Software were
used as input ﬁles for Agilent ChIP Analytics software
for data extraction and visualization. Microarray data
was normalized using default settings of Intra-array
Lowess (intensity-dependent) normalization, Whitehead
Error Model v1.0 in the ‘ChIP analytics’ software
(Supplementary Figure S1). For data analysis and visual-
ization in graphical form, human genome build May 2004
Nucleic Acids Research,2011, Vol.39, No. 9 3595was used as per designed microarray chip probes, in
custom track of UCSC genome browser (http://genome
.ucsc.edu).
Bisulﬁte sequencing
The sodium bisulﬁte modiﬁcation method was used to
analyze DNA methylation of selected CpG island as
described previously (33). In brief, DNA was digested
with the appropriate enzyme and then denatured before
sodium bisulﬁte treatment. The DNA sample was mixed
with two volumes of low melting point agarose and kept at
50C. The bisulﬁte modiﬁcation solution (1.9g of sodium
bisulﬁte dissolved in 2.5ml of water and 750mlo f2 M
NaOH) and hydroquinone solution (0.055g dissolved in
500ml of water) were made separately at 50C and then
combined and ﬁltered in the dark. Beads from 10ml
aliquots of each DNA-agarose mix were made in
mineral water, which was then transferred to the bisulﬁte
modiﬁcation solution. Once the beads were in the lower
bisulﬁte solution, the tubes were incubated on ice for
30min and then at 50C for 3.5h. After the incubation,
the solution was removed and beads were washed before
using for PCR. Two rounds of PCR were used to amplify
the targets, which were then cloned in a T-overhang vector
for sequencing. To obtain the methylation proﬁle, a few
clones were analyzed for each sample. The efﬁciency of
bisulﬁte conversion was analyzed by calculating the per-
centage conversion of cytosines in non-CpG context. In
our study, the non-CpG ‘C to T conversion rate’ was
97.1±0.62 (standard error of mean).
Quantitative PCR
The chromatin prepared for the ChIP-on-chip study was
also used to perform subsequent ChIP-qPCR validation
on a panel of 13 loci selected from the array data. ChIP
was performed on chromatin from 25000 cells using
LowCell ChIP Kit (Diagenode, #kch-maglow-A16) fol-
lowing the manufacturer’s protocol. Brieﬂy, sonicated
chromatin was incubated without any antibody (no
antibody) or with 1mg of H3K9me3 (abcam, #ab8898)
or H3K27me3 (Millipore, #07-449) antibody or 2mgo f
H3K9ac (abcam, #ab4441) or non-speciﬁc IgG
(Diagenode, #kch-803-015) antibody bound to protein A
coated paramagnetic beads. An aliquot of the same
cross-linked and sonicated chromatin was kept aside as
input DNA and puriﬁed in parallel. Following elution
and puriﬁcation of the immunoprecipitated DNA,
relative abundance at target loci was estimated using
Power SYBR Green qPCR Master mix (Applied
Biosystems) on an ABI7900HT Fast Real-Time PCR
System (2min at 50C; 10min at 95C; 40 cycles of 15s
at 94C, 30s at 60C and 30s at 68C, followed by dis-
sociation curve analysis). Enrichment in the ChIP DNA
was determined relative to the no-antibody control using
the dCt method. Enrichment was determined from three
independent sets of ChIP assays performed on chromatin
from the South Indian sample. Statistical signiﬁcance of
the enrichment was calculated using the Wilcoxon paired
t-test on the raw data (34). Primer sequences for all the
loci tested are provided in Supplementary Table S1.
RESULTS
Coverage of epigenetic analysis and validation
We mapped H3K9me3, H3K9ac, H3K27me3 histone
modiﬁcations and CTCF binding sites on the Y chromo-
some of two individuals from two distinct Indian popula-
tions—from North and South India—as biological
duplicates. As a technical replicate we performed anti
H3K9me3 and anti H3K9ac ChIP-on-chip analysis in du-
plicate with the South Indian sample. Considering the ex-
perimental and biological duplicates, we found that on an
average, 10330 of H3K9me3, 12542 of H3K9ac, 9952 of
H3K27me3 and 10497 of CTCF probes were signiﬁcantly
enriched, at enrichment log ratio 1. The global proﬁle of
epigenetic marks was found to be very similar and differ-
ences were statistically insigniﬁcant between the two indi-
viduals representing the two different populations,
although a large population size analysis is needed to
look for individual speciﬁc variations (Supplementary
Figure S2). Here we used a biological duplicate to ﬁnd
out if the global epigenetic proﬁle to see the degree of
similarity between the two distantly related individuals.
Considering the overall similarity in experimental and bio-
logical duplicates, we have discussed further only the data
obtained from the South Indian sample.
To further validate the ChIP-on-chip experiment we
performed independent ChIP assays followed by quanti-
tative real time PCR analysis for different histone
antibodies using WBCs from the blood sample used for
the ChIP-on-chip study. We selected a panel of 13 loci
spanning 7 unique genes (PLCXD, SRY, E1F1, DDX3Y,
SMCY, UTY and PRKY) and 3 duplicated genes (TSPY,
DAZ and CDY) that showed distinct epigenetic patterns
in the array data and validated the trend of enrichment
with histone antibodies across these loci. To validate the
sharply changing pattern in PLCXD, TSPY and DAZ loci
(as discussed below), we selected two probes in each case.
We observed striking similarity in the two data sets
between the relative enrichments of the chromatin
marks across the Y-chromosome genes (Supplementary
Figure S3). More than 90% of the tested unique loci
showed good correlation of ChIP-on-chip results with
ChIP-qPCR. The duplicated loci also showed good
correlation and, more interestingly, as in case of
ChIP-on-chip results, ChIP-qPCR also showed low en-
richment with these antibodies. These observations not
only support our results but also suggest that duplicated
loci can be studied for epigenetic modiﬁcations using this
approach. ChIP-qPCR results conﬁrmed that H3K9ac
mark was most abundant around the promoters of
E1F1, SMCY, PRKY and DDX3Y, which are expressed
in blood cells while silenced SRY gene appeared to be
mostly associated with the repressive marks of
hetero-chromatinization, with high methylation at H3K9
as well as H3K27. These results effectively validate the
observed ChIP-on-chip patterns of the histone marks
and conclusions drawn about the epigenetic patterns
across the Y-chromosome from the array data.
As DNA methylation and histone methylation are
linked processes we evaluated the DNA methylation
status at CpG residues of speciﬁc loci to elucidate its
3596 Nucleic Acids Research, 2011,Vol.39, No. 9role in gene regulation with histone modiﬁcation. We per-
formed DNA methylation analysis of 18 CpG islands
present within the promoter of 9 protein-coding genes
(SRY, RPS4Y1, TGIF2LY, TSPY, TBL1Y, CYorf16,
DDX3Y, TMSB4Y and VCY1B) and two non-coding
genes (TTTY7 and TTTY18). These loci were selected
on the basis of their biological importance and observed
histone marks. Among these, 6 loci had H3K9ac
coinciding with unmethylated CpG islands while 11 loci
had H3K9me3 coinciding with methylated CpG islands
(Supplementary Table S2). As expected all tested loci
followed the conventional relation between H3K9 modiﬁ-
cation and DNA methylation and further strengthened
our analysis.
Global pattern of histone marks on Y chromosome and
gene expression
The euchromatin region of the human Y chromosome has
been divided into distinct classes of sequences, viz.,
pseudoautosomal, X-transposed, X-degenerate and
ampliconic, on the basis of their origin (13). Globally,
we observed that distinct class of sequences, distributed
in different regions of the chromosome, showed distinct
histone marks whereas sequences of the common origin
showed similar epigenetic pattern (Figure 1). To further
conﬁrm our visual observations, we calculated average en-
richment value for the histone marks in distinct classes of
sequences. As expected, different classes of sequences
showed a pattern similar to that obtained by visual
analysis (Figure 1B). The pseudoautosomal regions
present on the ends of both the arms showed predominant
enrichment of H3K9ac over H3K9me3 and H3K27me3.
In contrast, the X-transposed sequences were more
enriched with H3K9me3, while X-degenerate region
followed a pattern similar to that of pseudoautosomal
region. Most interestingly, ampliconic regions showed
lower enrichment with all the three histone modiﬁcation
marks used in this study. Although all these histone marks
showed lower enrichment in the ampliconic regions,
H3K9me3 was still found to be the predominant mark.
The pattern of histone marks shows such a clear pattern
across the chromosome that different kind of sequences
can be distinguished based on the epigenetic pattern
(Figure 1A). These observations suggest that evolution
of different sequences in the Y chromosome have
Figure 1. Association of histone marks with different sequences of the Y chromosome. (A) Features of the Y chromosome are shown on the top,
telomere, centromere and heterochromatin (black), and euchromatin. Different kinds of sequences in euchromatin are represented as colored blocks
on the chromosome, blue (pseudoautosomal region), green (X-degenerate), red (X-transposed) and yellow (ampliconic). To visualize the data clearly,
both enriched and not enriched regions have been shown for H3K9me3, H3K9ac and H3K27me3 histone modiﬁcations in dark red, blue and orange,
respectively (the same convention has been followed in all the other ﬁgures also). We observe a speciﬁc global pattern of histone marks in different
classes of sequences—the pseudoautosomal region is predominately enriched with H3K9ac, the X transposed is enriched with H3K9me3, the
X-degenerate region shows almost equal enrichment with all marks and the ampliconic regions show a low enrichment with all histone marks,
H3K9me3 being the most enriched. (B) Here we show the average enrichment of histone marks in different classes of sequences distributed along the
chromosome. As visually observed in Figure 1A, different classes of sequences have a global pattern of histone marks. The pattern of histone marks
in different class of sequences followed the visual observation except in the case of X-degenerate region. In visual analysis X-degenerate is enriched
equally with H3K9me3 and H3K9ac but when we calculated average enrichment in different region we found that H3K9ac is more enriched than
H3K9me3. In the given table, each class of sequences, from short (p) and long (q) arm are clubbed together to simplify the table.
Nucleic Acids Research,2011, Vol.39, No. 9 3597distinct epigenetic footprints. This also implies that on a
global scale, during evolution, these sequences have not
diverged enough to adapt different epigenetic patterns or
functional states.
We also analyzed the association of histone marks and
CTCF enrichment upstream to the transcription start site
(up to 1kb upstream promoter sequence) of each gene in
the different classes of sequences. The enrichment of
histone marks and CTCF within 1kb from transcrip-
tional start site (TSS) was calculated using UCSC
genome browser. Surprisingly, we observed that the
genes present in a class of sequences showed a pattern of
H3K9ac, H3K9me3 and H3K27me3 modiﬁcations similar
to the global epigenetic pattern of that class. For example,
genes present in the pseudoautosomal and X-degenerate
regions were predominantly enriched with H3K9ac, genes
in the X-transposed region were mostly enriched with
H3K9me3 and genes in the ampliconic regions were
found to be generally poor in all the examined histone
marks at the TSS, with H3K9me3 showing predominant
enrichment (Table 1). These observations suggest that
there may be a global regulation operating to regulate
one kind of sequences. Most surprisingly, a global regula-
tion of similar kind of sequences is also borne out by the
fact that genes present in same class of sequences follow
same expression pattern.
To further understand epigenetic output in terms of
gene expression, we compared our histone modiﬁcation
data with gene expression data of human blood cells
from the UCSC genome browser (GNF Expression
Atlas 2 Data from U133A and GNF1H) (35). Hyper-
acetylation of H3K9 was observed at the promoters of
44 genes, of which 28 genes are known to express in
blood cells and for 2 genes expression pattern is
unknown. The remaining 14 genes that do not express in
blood cells indicate a different mechanism of repression
that can tolerate the presence of H3K9ac. We also found
that of the 47 genes associated with H3K9me3, 27 are not
expressed in blood cells and for 18 genes expression data is
not available. Only two genes (both the copies of PRY) are
known to express in blood cells in spite of H3K9me3 en-
richment. This analysis suggested that although at most
of the genomic loci, H3K9me3 and H3K9ac regulate the
loci as per conventional rule, there are a few exceptions.
In our analysis, at many loci, the gene expression proﬁle
and H3K27me3 enrichment did not correlate well while
H3K9me3 and H3K9ac showed better agreement with the
expression status (Table 1). This observation suggests a
mechanism whereby H3K9me3 and H3K9ac dominate
over H3K27me3 modiﬁcation to set the expression state
of the chromatin, which can be further regulated by other
sets of histone modiﬁers. Finally, there were instances
when none of the tested modiﬁcations were enriched
indicating the presence of other histone modiﬁcations
and mechanisms to regulate the expression of those genes.
Tandem repeats and epigenetic modiﬁcations
The Y chromosome is full of repeats, which were initially
thought to be junk, but now they are known to be import-
ant in maintaining the integrity of the Y chromosome in
the absence of meiotic recombination (13). One such class
of repeat is the tandem repeat which constitutes 10% of
human genome (36). These repeats are distributed in a
non-random fashion and clustered at coding regions,
near the centromere and telomeres (37). A change in the
number of tandem repeats is not neutral, and can affect
many basic cell processes like replication, transcription
and translation because they recruit several factors
which can change the status of the chromatin (38,39).
Accordingly, we also took care to design probes from
tandem repeat regions unique to the Y chromosome with
their counterparts on the X chromosome. We found that
different tandem repeats associated with the Y chromo-
some are marked with a speciﬁc pattern of histone modi-
ﬁcations. Most of the repeats showed a precise and clean
pattern with the tested histone marks and CTCF binding.
Such tandem repeats were distributed at both genic and
intergenic regions. Figure 2A shows a locus of intergenic
tandem repeats present near the telomeric region of the p
arm. At this locus, tandem repeat-1 (each unit: 61bp) was
not enriched with any of the tested modiﬁcations, whereas
another tandem repeat-2 (each unit: 26bp) present
just next to it was enriched preferentially with H3K9ac
and CTCF. Epigenetic marks changed sharply with the
change of the repeat, with different repeats showing
their characteristic epigenetic marks and potential
functional value. Interestingly, genic tandem repeats
distributed near the TSS and introns of genes also
showed precise and clean association with the tested
histone marks and CTCF as observed for the intergenic
tandem repeats. In the case of P2RY8, PPP2R3B, CSF2R,
SHOX, ASMTL, IL3RA and GTPBP6 genes, tandem
repeats were clustered in the introns, while in the case of
PLCXD1 and ASMTL genes, they were clustered near the
TSS. For example, many tandem repeats are clustered
around TSS of PLCXD1 a gene, which is expressed in
blood cells. Each kind of tandem repeat has a pattern of
histone modiﬁcation and CTCF enrichment, which
sharply changes with the change of repeat. As marked in
Figure 2B, repeat-1 is highly enriched with H3K9ac and
H3K27me3, whereas the upstream repeat-2 region is not
enriched with any tested marks and repeat-3 is enriched
only with H3K9ac and CTCF. The CpG island distributed
around the TSS is enriched with H3K9ac, H3K27me3 and
CTCF. Interestingly, none of the tandem repeats at this
locus showed enrichment with H3K9me3. The observed
pattern of H3K9ac, H3K27me3 and CTCF marks on dif-
ferent tandem repeats suggests a domain of active chro-
matin, which correlates well with the known expression of
the PLCXD1 gene in blood cells. Precise and speciﬁc as-
sociation of tandem repeats with different histone modiﬁ-
cations shows that the presence of such repeats can change
the status of chromatin by interacting with different
factors like CTCF that can have regulatory consequences.
These repeats thus appear to act as regulatory elements
to recruit factors for transcriptional control of the gene.
As observed in the above mentioned cases, many
tandem repeats were not enriched with tested histone
modiﬁcations and CTCF, suggesting involvement of
other histone modiﬁcations, histone variants and factors
in the regulation of such repeats. Our observation of
3598 Nucleic Acids Research, 2011,Vol.39, No. 9Table 1. Analysis of histone marks and CTCF binding at promoter of the genes
S.No Gene symbol Known expression 
pattern in blood 
cells
H3K9me3
enrichment
H3K9ac
enrichment
H3K27me3
enrichment
CTCF
enrichment
0 Y 1 D X C L P 1
0 Y B 3 R 2 P P P 2
0 Y X O H S 3
0 Y A R 2 F S C 4
0 M A R 3 L I 5
0 Y 6 A 5 2 C L S 6
0 0 Y 2 f r o Y X C 7
0 Y L T M S A 8
0 0 M 8 Y R 2 P 9
0 0 Y ) s y x D ( A 7 1 S R F S 0 1
0 0 Y T M S A 1 1
0 0 Y 1 D E B Z 2 1
0 Y 9 9 D C 3 1
0 M Y R S 4 1
15 RPS4Y1 Y
0 Y Y F Z 6 1
17 TGIF2LY N
18 PCDH11Y M
19 TTTY23 0 0 A N
0 0 N 2 Y P S T 0 2
21 TTTY1 0 0 A N
22 TTTY2 0 0 A N
23 TTTY21 0 0 A N
24 TTTY7 0 0 N
25 TTTY8 0 0 N
26 AMELY N
27 TBL1Y N
0 M Y K R P 8 2
29 TTTY16 0 A N
30 TTTY12 0 A N
31 TTTY18 NA
32 TTTY19 NA
33 TTTY11 0 N
34 TTTY20 0 0 0 A N
0 0 0 N 1 Y P S T 5 3
36 AK093413 0 0 0 N
0 A N P A 3 Y M B R 7 3
38 TTTY8 0 0 0 N
39 TTTY7 0 0 0 N
(continued)
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S.No Gene symbol Known expression 
pattern in blood 
cells
H3K9me3
enrichment
H3K9ac
enrichment
H3K27me3
enrichment
CTCF
enrichment
0 4 TTTY21 0 0 0 A N
1 4 TTTY2 0 0 N
2 4 TTTY1 0 0 M
3 4 TTTY22 0 A N
4 4 TTTY23 0 0 0 A N
5 4 TTTY15 Y0
N Y 9 P S U 6 4
Y Y B D / Y 3 X D D 7 4
N Y T U 8 4
Y Y 4 B S M T 9 4
0 0 0 N B 1 Y C V 0 5
0 0 N Y C V 1 5
N Y 4 N G L N 2 5
0 0 0 A N B 2 Y D C 3 5
0 0 0 A N A 2 Y D C 4 5
0 0 A N Y R K X 5 5
56 HSFY1 N 0
57 HSFY2 N 0
0 M 4 2 D C 8 5
9 5 TTTY14 N
0 6 BCORL2 NA
0 M A 5 1 f r o Y C 1 6
0 0 Y Y C M S 2 6
3 6 JARID1D Y
4 6 TTTY10 N0
0 0 Y Y A 1 F A I E 5 6
0 0 A N 2 Y 4 S P R 6 6
0 N 1 A 1 Y M B R 7 6
0 0 N 1 F 1 Y M B R 8 6
9 6 TTTY13 0 0 0 N
0 N 1 D 1 Y M B R 0 7
0 N E 1 Y M B R 1 7
2 7 TTTY6B 0 0 N
0 0 0 Y Y R P 3 7
0 0 N 1 F 1 Y M B R 4 7
5 7 TTTY5 0 N
0 N J 1 Y M B R 6 7
7 7 TTTY6B 0 N
0 0 Y 2 Y R P 8 7
79 TTTY17A 0 0 0 A N
(continued)
3600 Nucleic Acids Research, 2011,Vol.39, No. 9non-conﬂicting histone patterns also suggests that all
the copies of the repeat carry the same histone marks.
Our ﬁndings imply that tandem repeats at several places
in the genome can have regulatory consequences.
Enrichment of CTCF at the tandem repeats suggests a
role for these sequences in chromatin-mediated regulation
of genome organization and transcription.
Y chromosome linked oncogenesis and epigenetic
regulation
In this study, we also analyzed a critical oncogenic region,
the gonadoblastoma locus on the Y chromosome (GBY),
which contains an array of the Testis-speciﬁc protein
Y-encoded (TSPY) and Testis transcript Y (TTTY)
genes. They have been linked to gonadoblastoma in
intersex patients, testicular germ cell tumors, prostate
cancer and other somatic cancers (20,24). TSPY shows
homology with the SET oncogenes and interacts with
Cyclin B protein, suggesting its role in the regulation of
cell proliferation (20). Furthermore, high expression of
TSPY in testicular and prostate cancer is implicated in
tumorigenesis (40). TSPY is present in an array on the
short arm of the Y chromosome and its number varies
from 20 to 40 (41,42). As these genes are present in an
array and show a high degree of similarity in DNA
sequence, we designed probes for nine copies of this
gene. We designed a few unique probes and used other
probes that could hybridize to all the copies of the
duplicated region. Surprisingly, we found that the epigen-
etic marks at this region are set in a repeating pattern
analogous to the repetitive unit of the TSPY genes. The
repetitive pattern of H3K9me3 modiﬁcation and CTCF
binding at the TSPY gene cluster has a 20.7kb epigenetic
repeat unit (Figure 3). H3K9me3 is highly enriched
around the start site of each TSPY gene and spreads
over a 6.4kb region. Enrichment of H3K9me3 starts
about 4kb upstream of the TSPY gene and peaks
around the transcription start site, diminishing gradually
towards the end of the gene. A small 1.6kb region, present
at the end of each 20.7kb epigenetic repeat unit is also
enriched with H3K9me3 and CTCF. Moreover, a 7.2kb
region, upstream of the gene between the two H3K9me3
rich sequences, is devoid of any modiﬁcations tested, while
a 5.5kb region (marked in blue) downstream of the gene
Table 1. Continued
S.No Gene symbol Known expression 
pattern in blood 
cells
H3K9me3
enrichment
H3K9ac
enrichment
H3K27me3
enrichment
CTCF
enrichment
80 DAZ1 N
81 DAZ2 N
0 0 0 N 1 Y D C 2 8
83 CSPG4LYP2 0 0 0 N
84 GOLGA2LY1 0 0 N
85 BPY2B NA 0 0 0 0
86 DAZ3 N
0 N 4 Z A D 7 8
88 TTTY17B 0 0 0 A N
89 BPY2C NA 0 0 0 0
90 GOLGA2LY2 0 0 N
91 CSPG4LYP1 0 0 0 N
0 0 0 N 1 Y D C 2 9
93 TTTY3 0 0 A N
0 N 3 Y R P S 4 9
95 SYBL1 Y
96 IL9R N 0
0 0 0 Y 2 8 6 3 6 0 C B 7 9
97 genes of the Y chromosome are listed as per their occurrence across the chromosome. Genes in rows of same color are present in the same kind of
sequences in the chromosome (pseudoautosomal-blue, X-transposed-light red, X-degenerate-light green and ampliconic-yellow). Column 3 shows
expression pattern of genes in whole blood and in different cell lineages of the blood. Expression status has been denoted as Y, Yes; N, No; M, Mix;
NA, Not Available. Histone modiﬁcations and CTCF enrichment within 1.0kb upstream of each gene has been listed in column 4 to 7. Number of
circles in each row denotes the average enrichment of histone marks and CTCF as calculated by UCSC browser. Each colored circle shows an
average enrichment value of 0.5 and 0 denotes average enrichment value less than 0.25. Globally we see that genes present in one class of sequence
show similar histone modiﬁcation pattern. Hyper acetylation at H3K9 was seen on promoters of genes present in pseudoautosomal and X-degenerate
regions while hyper methylation at H3K9 was observed on promoters of genes present in X transposed and ampliconic regions
Nucleic Acids Research,2011, Vol.39, No. 9 3601has minimal H3K9me3 and CTCF enrichment. We
also noticed overlapping CTCF binding and H3K9me3
enrichment, suggesting a link between the two, which
might contribute to a locus-speciﬁc epigenetic regulatory
combination. The speciﬁc and non-conﬂicting pattern of
H3K9me3 and H3K9ac histone modiﬁcations observed
suggests that all the copies of the gene are associated
with a comparable epigenetic state. This implies that the
regulatory sequences of TSPY genes have not diverged
after expansion and a common mechanism operates at
this region. We also analyzed DNA methylation at two
CpG islands upstream of the TSPY gene and found that
they were hyper-methylated, correlating with the repressed
state of TSPY in blood cells.
The oncogenic GBY locus also has an array of
a non-protein-coding gene, TTTY. We found that
the entire TTTY array showed high enrichment of
H3K9me3 in comparison with other tested histone
marks (Supplementary Figure S4). As expected, the pro-
moters of all TTTY genes at this locus also showed pre-
dominant enrichment of the H3K9me3 mark (Table 1).
Figure 2. Proﬁle of histone marks and CTCF with tandem repeats.
Histone modiﬁcation and CTCF binding proﬁle are shown at different
genomic coordinates with the tandem repeats. (A) Different kinds of
tandem repeats present next to each other are shown in the Y chromo-
some. Two big tandem repeats are numbered as 1 and 2. Tandem
repeat 1 does not show any enrichment with the tested antibodies
whereas repeat 2 is enriched with H3K9ac and CTCF. There are few
more tandem repeats on the right side of the tandem repeat 2, which
does not show enrichment with any of the tested antibodies. (B)
Multiple tandem repeats associated with the PLCXD1 gene (blue line
with arrow) have been shown with the histone modiﬁcation and CTCF
binding proﬁle. Tandem repeats have been marked in the ﬁgure as 1, 2
and 3. Tandem repeat-3 enriches with anti-H3K9ac and anti-CTCF,
tandem repeat-2 does not enrich with any of the tested antibodies
whereas repeat-1 is enriched with anti-H3K9ac and anti-H3K27me3.
Figure 3. Epigenetic pattern and CTCF binding at TSPY gene arrays.
Four genes of the TSPY array have been shown with their repetitive
histone modiﬁcation and CTCF distribution patterns. The proﬁle of
H3K9me3 was used to divide the whole region in the domains of
20.7kb (written in pink) and H3K9me3 demarcates each domain.
One domain has been shown below separately, divided in four parts
using colored lines (black, red, green and blue). The start site of the
gene is sharply enriched with H3K9me3, which shows highest peak and
then further decrease towards both the sides (6.4kb). In the
red-labeled (7.2kb) region none of the tested antibodies show any
enrichment whereas in the blue labeled (5.5kb) region, there is little
enrichment of H3K9me3 and CTCF. The black marked 1.6kb region
upstream of the gene also shows H3K9me3 and CTCF enrichment.
3602 Nucleic Acids Research, 2011,Vol.39, No. 9We analyzed the DNA methylation status in this region
and found the CpGs present in the region to be
methylated (Supplementary Table S2). These observations
suggest that H3K9me3 and DNA methylation are neces-
sary for repression of the TSPY and TTTY gene clusters
at the GBY locus.
Epigenetic marks at sex determining gene SRY
SRY gene (Sex determining region, Y chromosome
encoded), encodes a testis-determining factor essential
for differentiation of Sertoli cells to induce masculiniza-
tion of the embryonic gonad. Despite the key role played
by SRY in genital development, its epigenetic proﬁle has
not been well studied. We found CTCF to be enriched in
the region upstream of its TSS, with maximum binding
within the CpG island (Figure 4). Interestingly,
H3K9me3 was absent from the region of maximum
CTCF binding, whereas H3K9ac and H3K27me3 were
enriched. H3K9ac and H3K27me3 histone modiﬁcations
taper down from the CTCF peak to the body of the gene,
while enrichment of H3K9me3 starts from the transcrip-
tion start site. As DNA methylation eliminates binding of
CTCF to its recognition sites (43), it is interesting to note
that bisulﬁte analysis found this CpG island to be
unmethylated. High enrichment of H3K27me3 next to
the CTCF binding supports the hypothesis that CTCF
has the ability to recruit members of the PRC2 complex
(44,45), and presents a potential mechanism for the repres-
sion of the SRY gene in blood cells. This interesting
epigenetic pattern exempliﬁes a chromatin-mediated sup-
pression mechanism based on recruitment of repressive
factors by CTCF rather than by DNA methylation
mediated gene silencing. Finally, we observed a conﬂicting
pattern of H3K9ac and H3K9me3 marks within the gene
body. This could be because SRY is expressed in the
B-cell lineage but not in all other blood cell lineages.
These epigenetic marks reﬂected a novel mechanism that
represses the transcription of this gene in some blood cell
lineages.
Histone modiﬁcations at AZF locus
Almost all the ampliconic sequences on the long arm of
the chromosome are collectively called the Azospermia
factor (AZF). Deletion of the AZF has been observed in
a number of the human male related infertility cases. This
region has multiple palindromes, which go through
intra-chromosomal recombination’s, resulting in deletion
of the genes required for male fertility (46,47). The AZF
region contains DDX3Y, DBY, XKRY, EIF1AY,
RPS4Y2, RBMY, PRY, BPY, DAZ and CDY genes.
Our results showed a low enrichment of all tested
histone modiﬁcations in the AZF region. DDX3Y,
EIF1AY and XKRY genes were enriched with H3K9ac,
RBMY and CDY genes were enriched with H3K9me3,
RPS4Y2 and DAZ genes showed a mixed pattern,
whereas BPY did not show enrichment with any of the
tested antibodies (Table 1). We found that most of the
genes show a clean epigenetic pattern at different loci
except the multi-copy DAZ (Figure 5) gene and the
single copy RPS4Y gene. From this, we can reason that
the mixed pattern at the single copy gene RPS4Y is
because of the known differential expression in different
blood cell lineages. Moreover, duplicated DAZ genes
show enrichment with both H3K9me3 and H3K9ac, sug-
gesting a diversion of epigenetic regulation at different loci
after gene duplication, which may have led to changes in
gene regulation (Figure 5). This indicates that after dupli-
cation, the regulatory elements of at least one of the copies
have diverged to attain differential histone marks. The
differential expression pattern of all the copies of DAZ
has not been studied because of the high sequence simi-
larity. In a preliminary study, however, polymorphic
expression of DAZ gene copies was observed (48), sup-
porting the idea that after duplication, regulatory
elements of different copies of the DAZ gene have differ-
ent histone modiﬁcations and therefore different regula-
tion. As mutation in the DAZ gene region is correlated
with azospermia, the function of this gene is
non-redundant and essential; therefore, the cell has not
Figure 4. Epigenetic pattern of SRY gene. Co-ordinates of the SRY
gene in the chromosome are given above in the ﬁgure while the gene
body has been shown below. The genomic CpG island and the clone
use to analyse the methylation status of the island are shown below the
gene. We see a high enrichment of H3K9me3 at the start site and in the
body of the gene, while H3K9ac and H3K27me3 are enriched from the
body of the gene to upstream of the gene. A very clean enrichment of
CTCF was seen at the CpG island upstream of the gene.
Figure 5. Pattern of H3K9ac and H3K9me3 at DAZ gene loci.
It shows DAZ gene, a duplicated gene with conﬂicting histone marks.
The ﬁgure shows two copies of the DAZ gene, DAZ3 and DAZ4
present in opposite directions and the pattern of H3K9ac and
H3K9me3 marks. Both alleles show almost equal enrichment of
H3K9ac and H3K9me3 at their transcriptional start site.
Nucleic Acids Research,2011, Vol.39, No. 9 3603adopted to silence all copies of the gene. In contrast to the
TSPY gene cluster (where all the duplicated copies have
non-conﬂicting mark), only a few copies are preferentially
silenced to balance the copy number in the case of
duplicated DAZ gene.
DISCUSSION
Cell type-speciﬁc genome packaging deﬁnes the epigenome
set during cellular differentiation. Epigenetic marks have
been shown to specify the patterns of gene expression and
a number of whole-genome epigenetic mapping studies of
human cells have been done in the recent past to explore
the functional states across genome (2,49,50). None of
these, however, have explored the epigenetic signatures
on the Y chromosome (1,2,26,27), presumably because
of the presence of many repeats and the instability of
the chromosome in various cultured cell lines. In this
study, we have analyzed chromatin from WBCs and
designed Y chromosome speciﬁc probes from both
unique and duplicated regions to create an epigenetic
map of the human Y chromosome. Unique probes were
speciﬁc to unique regions of the Y chromosome, while
probes for multi-copy loci were designed from sequences
that are duplicated but are unique to Y chromosome and
regions having homologues on X chromosome.
The evolutionary origin of the sequences that constitute
the Y chromosome is known and it has been observed that
genes distributed in sequences of the same origin have a
similar expression pattern (13). We observed a global con-
servation of the epigenetic pattern associated with se-
quences of the same origin, which changed sharply at
sequences of different origin. This implies that similar
regulatory mechanisms might operate across genes that
share a common origin and epigenetic proﬁle, resulting
in their similar expression pattern (35). This also insinu-
ates that these sequences have not diverged enough to
have different functions after they became part of the Y
chromosome. Surprisingly, even regions of internal dupli-
cation within the Y chromosome showed non-conﬂicting
epigenetic marks in our analysis, suggesting that after du-
plication, the associated loci have maintained similar regu-
latory environments. For instance, all copies of the TSPY
and TTTY genes appear to be silenced in the WBCs by
mechanisms that involve methylation of H3K9 around
their promoters and methylation of DNA at associated
CpG islands. This locus has been linked to oncogenesis
and loss of methylation at both DNA and histone has
been observed at the promoters of oncogenes in many
cancers. It is possible that in the case of gonadoblastoma,
the GBY locus may be hypomethylated, resulting in
overexpression of TSPY and TTTY genes (51,52).
Therefore, it would be interesting to test the epigenetic
marks associated with this region in cancer tissues to
explore the epigenetic regulation of GBY loci in different
male-speciﬁc cancers.
Among the internally duplicated regions (palindromes)
on the long arm, only DAZ genes at the AZF locus
showed conﬂicting patterns of histone marks, suggesting
that in these clusters, different copies of the genes may be
regulated differently. It is possible that in the case of genes
with non-redundant functions, mechanisms have evolved
for silencing some of the copies to enable normal
functioning of the cell, as an alternative to maintaining
all the copies in a repressed or expressed state. The
non-conﬂicting histone patterns observed for the rest of
the duplicated genes suggest the ability of the cell to
function normally with multiple copies of these genes
being expressed after the duplication event. In the
absence of meiotic recombination, palindromes may
make the Y chromosome unstable, but our observation
of very similar epigenetic marks on duplicated regions in
contrast to expected results (53) indicates a regulatory
mechanism at play that maintains the integrity of the
Y chromosome in the absence of meiotic recombination
and keeps global epigenetic regulation unchanged during
evolution (16,46).
In this study, we have used proﬁles of histone modiﬁ-
cations and CTCF binding to explore and correlate
the transcriptional potential of most of the genes of the
Y chromosome. The association of CTCF with different
marks of histone and DNA methylation in the case of
SRY, TSPY and tandem repeats suggests how epigenetic
changes may lead to chromatin-mediated regulation
of different coding and non-coding components of the
genome. Interestingly, non-overlapping enrichment of
H3K9me3 and DNA methylation at CpG islands of
SRY and overlapping enrichment of the two at TSPY
locus suggests that same epigenetic tools can be used dif-
ferently at different loci. This also suggests the differential
regulation of H3K9me3 modiﬁcation and CTCF binding
at each locus by other locus-speciﬁc factors. As observed
in genic regions, we found distinct patterns of histone
modiﬁcations and CTCF binding associated with different
tandem repeats as well. Our data indicates that tandem
repeats are capable of recruiting different kinds of chro-
matin modiﬁers, irrespective of their position, by virtue of
their association with speciﬁc histone marks and this may
play a role in setting the functional state of the chromatin.
This suggests a non-neutral role for tandem repeats in
recruiting various epigenetic regulatory factors. Since
tandem repeats are known to be associated with almost
every component of the genome, their epigenetic regula-
tion can govern a large number of genomic loci by
inﬂuencing many important cell processes like genome or-
ganization, replication and transcription. As CTCF is a
transcriptional repressor and also binds with chromatin
insulators (44), in these cases it may coordinate transcrip-
tion of genes through higher order chromatin-mediated
regulation.
This analysis also provides a way to study the epigenetic
proﬁle associated with multi-copy genes as a representa-
tion of the average pattern across all the copies. Analysis
of ChIP data from probes representing repeated regions
carries a risk of misinterpretation, however a cautious
approach can yield new insights into the possible mechan-
isms of global epigenetic regulation. When duplicated loci
carry the same epigenetic marks, the epigenetic pattern is
observed to be non-conﬂicting with a clear association
with speciﬁc marks, whereas in cases where the duplicated
genes have diverged signiﬁcantly and have distinct
3604 Nucleic Acids Research, 2011,Vol.39, No. 9epigenetic marks, conﬂicting histone modiﬁcations can be
expected. This strategy is, therefore, useful in identifying
the diversion in epigenetic regulation at duplicated loci.
As our understanding of histone marks and their func-
tional meaning increases, it is becoming more and more
apparent that the functional status of a locus is decided by
a complex histone code based on a combination of
multiple histone modiﬁcations (3,7). Further mapping of
other known histone marks, histone variants and chroma-
tin modiﬁers would, therefore, be extremely useful in
understanding various Y chromosome associated diseases.
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